ISRCTN10567920.

Study name	A pragmatic, cluster randomized trial evaluating the impact of an enhanced adherence package (dual bronchodilator+add‐on+app) on time to treatment failure and other clinical outcomes in exacerbating COPD patients with poor adherence to mono or dual therapy over one year (MAGNIFY)
Methods	Randomly assigned participants from selected GP practices to either use the technology when taking their daily inhaler dose or usual patient care for 12 months
Participants	People with COPD
Interventions	Device to monitor inhalation attached to Ultibro inhaler, reminders sent via smartphone application
Outcomes	Exacerbations, medication use
Starting date	13 June 2019
Contact information	rupert.jones@plymouth.ac.uk
Notes